Scientists have gotten the first close look at one of two co-receptors HIV uses to get its foot in the door of the immune system, a new study reports. Their insights could lead to better HIV drugs.
CCR5, a receptor on the surface of human cells, is one of two main entry points the HIV virus uses to initiate its attack on the human immune system; by binding to it, an HIV protein can fuse to the cell membrane beneath, ultimately digging its way inside the cell.
The other receptor that HIV uses to perform this feat is CXCR4.